(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...

Data in and of itself can be interesting, but the true value of data lies in how you use it and the insights that come from ...

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, ...

AI has the power to transform healthcare and life sciences, reducing costs, improving outcomes and accelerating discoveries.

A patient with a rare illness would have died if it weren't for AI-powered drug repurposing: When side effects come to the ...

Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

Proving your product to be safe and effective while also getting buy-in from the healthcare ecosystem are only some of the ...

Powered by Real-World Expertise: Cliniphai has built deep operational experience across clinical studies and is working with trusted partners that have spent decades ensuring linguistic accuracy in ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

The American Gastroenterological Association (AGA) released a new clinical guideline making no recommendation—for or ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for ...